학술논문
HTA34 Quo Vadis Benefit Assessment for Orphan Drugs in Germany: The End of the Exception?
Document Type
Abstract
Author
Source
In Value in Health December 2022 25(12) Supplement:S302-S302
Subject
Language
ISSN
1098-3015